We-INtervention Among Chinese HIV-serodiscordant Male Couples

ConditionHIV
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorCity University of Hong Kong

About this trial

HIV-serodiscordant male couples, in which one male partner is HIV-seropositive and the other is HIV-seronegative, experience multiple risks in HIV care and prevention. As stigma often hinders such couples' access to support and services, leveraging their relational resources is crucial for optimizing their outcomes. The proposed study will assess the efficacy of the three-session We-INtervention focusing on their relationship dynamics to enhance Chinese HIV-serodiscordant male couples' health and well-being.

A total of 160 Chinese HIV-serodiscordant male couples (320 individuals: 160 HIV-seropositive and 160 HIV-seronegative) will be randomized at a 1:1 ratio to either the intervention or control arm. In the intervention arm, the We-INtervention will be delivered to both partners of each couple separately. In the control arm, each couple will receive health information pamphlets.

Eligibility criteria

Qualifiers

both partners are male,

both partners are aged 18 or above,

both partners report being in a committed relationship for at least 3 months,

one partner is HIV-seropositive and the other partner is HIV-seronegative (i.e., serodiscordant couple),

Disqualifiers

either partner is unable to complete the assessment due to a low education level or to physical or psychological constraints and

either partner has been diagnosed with another chronic disease (e.g., cancer and coronary heart disease).

Trial design

Treatments tested in this trial

  • We-INtervention
  • Usual Care Group

Treatment groups

320 Participants
are divided into 2 treatment groups

Sponsors and collaborators